-
Class
Non-depolarizing Neuromuscular Blocking Agent
-
Pharmacology and Actions
- - Onset: 1-3 minuets
- - Duration: 30-60 minuets
- - Minimal effect on heart rate and blood pressure
- - Causes chemical muscle paralysis for intubation
- - Vecuronium competes with acetylcholine for cholinergic receptor sites on post-junctional neuromuscular membranes
- - A sedative, such as Versed or Etomidate, must be given in conjustion with Vecuronium
-
Indications
To maintain muscular paralysis following successful Rapid Sequence Induction (RSI) Intubation
-
Contraindications
- - Hypersensitivity
- - Inability to control the airway (non-intubated patient)
-
Precautions and Side Effects
- - ONLY use after successful intubation with use of Succinylcholine as initial paralytic
- - Wheezing, aspiration, dysrhythmias, bradycardia, sinus arrest, hypertension, hypotension, increased intracranial pressure
-
Dosage (Adult and Pedi)
0.1 mg/kg to a max single dose of 10mg - mayr repeat in 30-40 mins as needed - watch for patient movement
-
How Supplied
10mg / 10mL vials
|
|